Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Breast pain, Breast tenderness, Erythema, Injection site pain
Clinical narrative: Developed hot, deep red itchy skin on both arms, from mid upper arm continuously to the tops of hands. Both palms were also red and itchy. Both kneecaps were itchy and red. Both feet were itchy and red on the tops and bottoms.; Developed hot, deep red itchy skin on both arms, from mid upper arm continuously to the tops of hands. Both palms were also red and itchy. Both kneecaps were itchy and red. Both feet were itchy and red on the tops and bottoms.; Developed red, itchy blotches over face.; Also developed hot, deep red itchy skin on both arms, from mid upper arm continuously to the tops of hands.; Tenderness in right breast between armpit and right side of breast; Moderate tenderness in the injection site of right arm muscle area; Moderate pain and tenderness in right breast between armpit and right side of breast; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Apr2021 at 10:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) and daily vitamin (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications and unknown if ongoing.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 10:15, within 15 minutes of the injection, the patient developed moderate tenderness in the injection site in right arm muscle area and at the same time also developed moderate pain and tenderness in right breast between armpit and the right side of breast. The breast tenderness continued from 15 minutes post injection on 12Apr2021 until 17Apr2021. On 13Apr2021, on the morning following first injection, approximately 24 hours post injection, the patient developed red, itchy blotches over the face, also developed hot, deep red itchy skin on both the arms from mid upper arm continuously to the tops of the hands and both palms, kneecaps and feet top and bottoms were also red and itchy. The symptoms continued for approximately two and a half hours before dissipating. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tenderness in right breast between armpit and right side of breast was recovered on 17Apr2021; while that of the moderate tenderness in the injection site of right arm muscle area and moderate pain in right breast between armpit and right side of breast was recovered on an unknown date in Apr2021. The clinical outcome of the events red, itchy blotches over the face, also developed hot, deep red itchy skin on both the arms from mid upper arm continuously to the tops of the hands and both palms, kneecaps and feet top and bottoms were also red and itchy was recovered on 13Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.